209 related articles for article (PubMed ID: 19816665)
1. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.
Ishii M; Kojima N
Glycoconj J; 2010 Jan; 27(1):115-23. PubMed ID: 19816665
[TBL] [Abstract][Full Text] [Related]
2. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
4. Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.
Yoshikawa T; Uchida T; Naito S; Horino A; Taneichi M; Kato H; Komuro K; Nakano Y; Mori M; Nishinohara S; Chiba J; Kurata T; Tamura S
Int Arch Allergy Immunol; 2000 Feb; 121(2):108-15. PubMed ID: 10705220
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose.
Matsuoka Y; Kawauchi Y; Kawauchi K; Takiyama A; Kojima S; Kuroda Y; Kojima N
Glycoconj J; 2019 Jun; 36(3):185-197. PubMed ID: 31016559
[TBL] [Abstract][Full Text] [Related]
6. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
[TBL] [Abstract][Full Text] [Related]
7. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity.
Kojima N; Biao L; Nakayama T; Ishii M; Ikehara Y; Tsujimura K
J Control Release; 2008 Jul; 129(1):26-32. PubMed ID: 18485512
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.
Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G
Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635
[TBL] [Abstract][Full Text] [Related]
9. Importance of particle size of oligomannose-coated liposomes for induction of Th1 immunity.
Matsuoka Y; Onohara E; Kojima N; Kuroda Y
Int Immunopharmacol; 2021 Oct; 99():108068. PubMed ID: 34426114
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
Vadolas J; Davies JK; Wright PJ; Strugnell RA
Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
[TBL] [Abstract][Full Text] [Related]
12. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues.
Takagi H; Furuya N; Kojima N
Cytokine; 2007 Dec; 40(3):241-50. PubMed ID: 18060800
[TBL] [Abstract][Full Text] [Related]
13. Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.
Marinaro M; Di Tommaso A; Uzzau S; Fasano A; De Magistris MT
Infect Immun; 1999 Mar; 67(3):1287-91. PubMed ID: 10024572
[TBL] [Abstract][Full Text] [Related]
14. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-6 in antigen-specific mucosal immunoglobulin A induction by cationic liposomes.
Tada R; Hidaka A; Tanazawa Y; Ohmi A; Muto S; Ogasawara M; Saito M; Ohshima A; Iwase N; Honjo E; Kiyono H; Kunisawa J; Negishi Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):108280. PubMed ID: 34710845
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
[TBL] [Abstract][Full Text] [Related]
17. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
18. Targeting with oligomannose-coated liposomes promotes maturation and splenic trafficking of dendritic cells in the peritoneal cavity.
Ishii M; Kato C; Hakamata A; Kojima N
Int Immunopharmacol; 2011 Feb; 11(2):164-71. PubMed ID: 21112331
[TBL] [Abstract][Full Text] [Related]
19. Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity.
Jiang PL; Lin HJ; Wang HW; Tsai WY; Lin SF; Chien MY; Liang PH; Huang YY; Liu DZ
Acta Biomater; 2015 Jan; 11():356-67. PubMed ID: 25242652
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
